ESC Premium Access

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 31 August 2019

Congress Session

13 presentations in this session

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Speaker: Doctor I. Hammami (Oxford, GB)
Thumbnail

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Speaker: Doctor A. Conti (Massa, IT)
Thumbnail

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Speaker: Doctor A. Baluja (Santiago de Compostela, ES)
Thumbnail

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Speaker: Doctor A. Katbeh (Aalst, BE)
Thumbnail

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Speaker: Professor D. Linz (Maastricht, NL)
Thumbnail

Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

Speaker: Doctor M. Proietti (Milan, IT)
Thumbnail

Identifying patients at risk for atrial fibrillation in the community: a systematic review and meta-analysis of prediction models

Speaker: Doctor J. Himmelreich (Amsterdam, NL)
Thumbnail

Impact of dynamic change in the status of metabolic syndrome associated with the risk of atrial fibrillation: a nationwide population-based study

Speaker: Doctor S. Lee (Seoul, KR)
Thumbnail

Incidence and predictors of intracerebral haemorrhage recurrence in patients with and without atrial fibrillation: a cohort study

Speaker: Doctor T. Overvad (Aalborg, DK)
Thumbnail

Anti-platelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: randomised controlled proof of concept trial (APPLE COPD-ICON 2)

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Thumbnail

13 speakers from this session

Doctor Imen Hammami

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Alberto Conti

Apuane General Hospital Northwest Tuscany HealthCare, Massa (Italy)
0 follower

Doctor Aurora Baluja

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
0 follower

Doctor Asim Katbeh

Olv Hospital Aalst, Aalst (Belgium)
1 presentation
0 follower

Professor Dominik Linz

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
14 presentations
5 followers

Doctor Marco Proietti

University of Milan, Milan (Italy)
6 presentations
0 follower

Doctor Jelle Caspar Lorenz Himmelreich

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

Doctor Seo-Young Lee

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

Doctor Thure Filskov Overvad

Aalborg University, Aalborg (Denmark)
0 follower

Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
10 presentations
0 follower

Doctor Lorenzo Martin Lobo

Campo de Mayo Military Hospital, Buenos Aires (Argentina)
0 follower

Doctor Georg Gelbenegger

Medical University of Vienna, Vienna (Austria)
0 follower

Doctor Juan Gomez-Mesa

Valle del Lili Foundation, Cali (Colombia)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk